These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 6668312)
1. Simultaneous high-performance liquid chromatographic analysis of omeprazole and its sulphone and sulphide metabolites in human plasma and urine. Mihaly GW; Prichard PJ; Smallwood RA; Yeomans ND; Louis WJ J Chromatogr; 1983 Dec; 278(2):311-9. PubMed ID: 6668312 [TBL] [Abstract][Full Text] [Related]
2. Determination of omeprazole and metabolites in plasma and urine by liquid chromatography. Lagerström PO; Persson BA J Chromatogr; 1984 Aug; 309(2):347-56. PubMed ID: 6480786 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 column. Kobayashi K; Chiba K; Sohn DR; Kato Y; Ishizaki T J Chromatogr; 1992 Sep; 579(2):299-305. PubMed ID: 1429977 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine. Bradbrook ID; John VA; Morrison PJ; Rogers HJ; Spector RG Br J Clin Pharmacol; 1982 Feb; 13(2):177-85. PubMed ID: 7059415 [TBL] [Abstract][Full Text] [Related]
5. Reversed-phase ion-pair high-performance liquid chromatographic determination of triclabendazole metabolites in serum and urine. Negro A; Alvarez-Bujidos ML; Ortiz AI; Cubría JC; Méndez R; Ordóñez D J Chromatogr; 1992 Apr; 576(1):135-41. PubMed ID: 1500447 [TBL] [Abstract][Full Text] [Related]
6. Stereospecific and simultaneous high-performance liquid chromatographic assay of flosequinan and its metabolites in human plasma. Kashiyama E; Odomi M; Shimizu T J Chromatogr; 1994 Feb; 652(2):179-85. PubMed ID: 8006102 [TBL] [Abstract][Full Text] [Related]
7. Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study. Uno T; Yasui-Furukori N; Shimizu M; Sugawara K; Tateishi T J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):238-43. PubMed ID: 16087412 [TBL] [Abstract][Full Text] [Related]
8. Effect of hypoxia on oxidative and reductive pathways of omeprazole metabolism by the isolated perfused rat liver. Webster LK; Jones DB; Mihaly GW; Morgan DJ; Smallwood RA Biochem Pharmacol; 1985 Apr; 34(8):1239-45. PubMed ID: 3994745 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of omeprazole and their main metabolites in human urine samples by capillary electrophoresis using electrospray ionization-mass spectrometry detection. Nevado JJ; Peñalvo GC; Dorado RM; Robledo VR J Pharm Biomed Anal; 2014 Apr; 92():211-9. PubMed ID: 24530982 [TBL] [Abstract][Full Text] [Related]
10. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study. Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821 [TBL] [Abstract][Full Text] [Related]
11. Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes. Shimizu M; Uno T; Niioka T; Yaui-Furukori N; Takahata T; Sugawara K; Tateishi T J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):241-8. PubMed ID: 16497565 [TBL] [Abstract][Full Text] [Related]
12. Direct injection/h.p.l.c. methods for the analysis of drugs in biological samples. Doyle E; Huber R; Picot VS Xenobiotica; 1992 Jul; 22(7):765-74. PubMed ID: 1333685 [TBL] [Abstract][Full Text] [Related]
13. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. Tassaneeyakul W; Vannaprasaht S; Yamazoe Y Br J Clin Pharmacol; 2000 Feb; 49(2):139-44. PubMed ID: 10671908 [TBL] [Abstract][Full Text] [Related]
14. [Behavior of acid secretion under the long-term daily administration of omeprazol]. Dammann HG; Müller P; Seitz HK; Simon B Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940 [TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine. Aoki I; Okumura M; Yashiki T J Chromatogr; 1991 Nov; 571(1-2):283-90. PubMed ID: 1810958 [TBL] [Abstract][Full Text] [Related]
16. Relative bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated tablet in healthy Bangladeshi volunteers. Hasan A; Abul Kalam Azad M; Ullah MA; Mahbub Latif AH; Hasnat A Int J Clin Pharmacol Ther; 2009 Mar; 47(3):215-21. PubMed ID: 19281731 [TBL] [Abstract][Full Text] [Related]
17. A high performance liquid chromatographic method for the determination of febantel and its major metabolites in lamb plasma. Landuyt J; Debackere M; Delbeke F; McKellar Q Biomed Chromatogr; 1993; 7(2):78-81. PubMed ID: 8485378 [TBL] [Abstract][Full Text] [Related]
18. A simple and sensitive bioanalytical assay for simultaneous determination of omeprazole and its three major metabolites in human blood plasma using RP-HPLC after a simple liquid-liquid extraction procedure. Rezk NL; Brown KC; Kashuba AD J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Dec; 844(2):314-21. PubMed ID: 16920412 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of astemizole and its demethylated metabolite in animal plasma and tissues by high-performance liquid chromatography. Woestenborghs R; Embrechts L; Heykants J J Chromatogr; 1983 Dec; 278(2):359-66. PubMed ID: 6421861 [TBL] [Abstract][Full Text] [Related]
20. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study. Miner PB; Fort JG; Zhang Y Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]